Over the years we have seen significant updates to regulations and guidance across the medical devices, in vitro diagnostic and pharmaceutical sectors.
It is clearly well recognised that through the industry’s innovation in science and technology, the sectors have been evolving at an exponential rate.
The regulators have been embracing these innovations and developing and adapting regulatory frameworks to ensure safety, efficacy, transparency and traceability of drugs and devices on the market.
Check out the rest of the feature here
